First Header Logo Second Header Logo

Connection

Peter Clark to Chemotherapy, Adjuvant

This is a "connection" page, showing publications Peter Clark has written about Chemotherapy, Adjuvant.
Connection Strength

0.806
  1. Clark PE. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther. 2009 Jun; 9(6):821-30.
    View in: PubMed
    Score: 0.319
  2. Keegan KA, Resnick MJ, Clark PE. Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Curr Opin Oncol. 2012 May; 24(3):278-83.
    View in: PubMed
    Score: 0.098
  3. Morgan TM, Keegan KA, Clark PE. Bladder cancer. Curr Opin Oncol. 2011 May; 23(3):275-82.
    View in: PubMed
    Score: 0.091
  4. Bischoff CJ, Clark PE. Bladder cancer. Curr Opin Oncol. 2009 May; 21(3):272-7.
    View in: PubMed
    Score: 0.079
  5. Barocas DA, Clark PE. Bladder cancer. Curr Opin Oncol. 2008 May; 20(3):307-14.
    View in: PubMed
    Score: 0.074
  6. Clark PE. Bladder cancer. Curr Opin Oncol. 2007 May; 19(3):241-7.
    View in: PubMed
    Score: 0.069
  7. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG. Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Cancer. 2005 Feb 01; 103(3):546-52.
    View in: PubMed
    Score: 0.059
  8. Gwynn ES, Clark PE, Hall MC. Recent advances in the treatment of bladder cancer. Expert Rev Anticancer Ther. 2005 Dec; 5(6):1023-30.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.